Navigation Links
Molnlycke Drives 'Home' the Fight Against Staph and Other MRSA Infections
Date:9/20/2007

New Hibistat(R) Germicidal Towelettes Offer Consumers Convenience and

Reliability In Fight Against Super Germs

NORCROSS, Ga., Sept. 20 /PRNewswire/ -- Once almost exclusively confined to hospital settings, drug-resistant staph infections, such as MRSA (methicillin-resistant Staphylococcus aureus), are increasingly finding their way right through the front doors of homes across America.

Known as community-acquired MRSA (CA-MRSA), this strain of staph infection is found in individuals who have not been hospitalized or undergone a medical procedure within the past 12 months.(1) Outbreaks of CA-MRSA have been documented for more than 20 years(2), but recent reports indicate infections from this strain of staph are on the rise. MRSA and Staphylococcus aureus, in general, are germs that live on the skin of healthy people and spread from person to person on contaminated hands, skin and surfaces. It has the potential to become serious when it enters the body through scrapes and scratches potentially leading to blood and joint infections, pneumonia, and even death.

"We're definitely hearing more reported MRSA cases in the community, especially among active, healthy, young people," said Carolyn Twomey, RN, vice president of clinical and technical affairs, Molnlycke Health Care US. "Unfortunately, the spread of this type of MRSA stems, in large part, from individuals sharing close quarters and coming in contact with contaminated objects -- conditions we often see in schools, day cares, and locker rooms. It's easy to see how MRSA is now making its way into American households."

MRSA can survive for prolonged periods of time on common objects and surfaces, increasing the chances of cross-contamination and allowing it to be easily passed on to friends and family members. For example, MRSA can live for:

- 9 weeks on a towel;

- 14 days on formica;

- 6 months on dust;

- 56 days on a mop head; and

-
'/>"/>

SOURCE Molnlycke Health Care US, LLC
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Statement by Philip Home Chairman of the RECORD Study Steering Committee and Professor of Diabetes Medicine at Newcastle University in England
2. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
3. New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV
4. Neuroblastoma Expert Reviews Progress and Challenges in Fighting Difficult Pediatric Cancer
5. Alzheimers Drug Shows Promise in Fighting Cancer
6. Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight Against Cancer
7. Data on Telavancin and Micafungin Hold Promise of New Therapeutic Options in Fight Against Serious Infectious Disease
8. Viral Enzyme Recruited in Fight Against Ear Infection
9. RTA 402 Shown to Protect Animals Against Toxicities of Standard Cancer Treatments
10. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
11. In Vitro and In Vivo Data Show Alfacells Onocanse is Active Against Naive and Chemoresistant Neuroblastoma Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Patterson Medical, formerly the medical business ... is now an independent company with today,s completion ... by Madison Dearborn Partners (MDP).  ... transition period before rebranding as the world,s leading ...  With the focused resources and expertise of MDP, ...
(Date:8/28/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/sqh7xc/investigation ... Report on China,s Ranibizumab Market, 2012-2019" report to ... approved by CFDA to treat wet age- related macular ... of Novartis, is available in the Chinese market. However, ... for the treatment of wet AMD in ...
(Date:8/28/2015)... Company plc ("Perrigo") (NYSE: PRGO ; TASE) today ... OTC brands from GSK in an all cash transaction ... demonstration of Perrigo,s unique ability to maximize brand value ... countries.  Perrigo Chairman, President and CEO ... to complete this transaction, which clearly demonstrates our ability ...
Breaking Medicine Technology:Patterson Medical Positioned for Continued Growth as a Newly Independent Company 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 3Investigation Report on China's Ranibizumab Market, 2012-2019 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4
... MESA, Ariz., March 16, 2012 /PRNewswire/ -- On ... filed a collective action lawsuit against Sunovion Pharmaceuticals for failure ... are entitled under the Fair Labor Standards Act (FLSA). The Complaint ... District of Oregon on behalf of all Sunovion pharmaceutical reps ...
... Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ), a ... with inflammation and autoimmune disorders, today provided an update ... VISTA-16 clinical study. Immediately after the ... clinical study, the Company took steps to cease patient ...
Cached Medicine Technology:JacksonWhite Files Overtime Lawsuit Against Sunovion Pharmaceuticals 2Anthera Provides Corporate Update on Recent Activities 2
(Date:8/28/2015)... ... August 28, 2015 , ... Saint Petersburg, FL —Pocket Protein™, ... fat, carbs, sugar, gluten, lactose or caffeine in a convenient 2 oz. pouch ... CPG Editor’s Choice Awards. , Five consumer packaged goods (CPG) products were selected ...
(Date:8/28/2015)... ... 2015 , ... Altima Technologies, Inc., the maker of popular ... assets and audio-video devices, recently released Visio Stencils for the following product lines: ... EMC VNX Series , Super Micro Computer SuperStorage, Hitachi Data Systems Virtual Storage ...
(Date:8/28/2015)... ... 2015 , ... Medical Solutions, one of the nation’s largest travel nurse staffing ... by Modern Healthcare and will be honored at an awards dinner in Chicago ... Best Places to Work in Healthcare program recognizes outstanding employers in the healthcare industry ...
(Date:8/28/2015)... ... August 28, 2015 , ... CARF International announced that West ... day treatment and intensive family based services. , By pursuing and achieving accreditation, ... pursuit of excellence. As a nonprofit charity for more than 50 years, West ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... a low cost. Personalized with practice contact information and logos, Calendars stand alone ... can also incorporate Calendars into seasonal mailings, thank you and welcome communications, and ...
Breaking Medicine News(10 mins):Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 3Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 3Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2Health News:SmartPractice® Introduces 2016 Calendars for Dental Practice Giveaways 2
... long way to go before they can claim to be new generation ... their kids, according to a survey. ,The UK survey ... nearly every change and 16 percent men argue every time over the ... expert, although some men argue about the job, it might help the ...
... face different treatment options and determining which ones to ... patients decisions regarding therapy for RA and glucosamine for ... to change their treatment as long as their condition ... trial results for glucosamine. ,Recent advances in ...
... cerebral palsy hampered Anthonys ability to walk. He and his ... would be confined to a wheelchair. ,As is ... disorder, Anthony was left with few options and his family ... finding answers to effectively address his condition. ,They ...
... marketing authorization for INVEGA(TM) (paliperidone prolonged release ... treatment of schizophrenia. This once-daily medication ... the active ingredient in INVEGA - through ... ,In clinical trials, INVEGA demonstrated significant ...
... affects learning have found that boys and girls are ... ,However, they have suggested that this ... from co-educational to segregated schools, or vice-versa. ... University in NSW, said that the key to this ...
... the first success in "decrypting" an enzyme's function from its ... drug discovery. ,Led by UCSF's Brian Shoichet, ... Frank Raushel of Texas A and M, the study offers ... many of the most successful drugs work by blocking enzyme ...
Cached Medicine News:Health News:Alternative Treatments for Arthritis 2Health News:Alternative Treatments for Arthritis 3Health News:Motion Analysis Helps Teen With Cerebral Palsy Regain Ability to Walk 2Health News:Motion Analysis Helps Teen With Cerebral Palsy Regain Ability to Walk 3Health News:INVEGA(TM) Gets Marketing Authority from EU to Treat Schizophrenia 2Health News:INVEGA(TM) Gets Marketing Authority from EU to Treat Schizophrenia 3Health News:Boys and Girls are Different by Nature and Learn in Different Ways 2Health News:"Decryption" of Enzyme's Functions Paves Way for Future Drug Discovery 2
... 50 Urine Chemistry Analyzer is designed for use ... time for technicians, allowing them to be more ... It has a throughput of 50 strips per ... results, which may be downloaded to a computer ...
... collection under vacuum process makes the ... reduction. ,The Optivac® Vacuum Mixing ... of continuous improvement since its original ... a consistently high-quality, homogenous cement, with ...
... 35 years, Palacos® Bone Cement has ... standard in cemented arthroplasty. Palacos® is ... gentamicin, providing an antibiotic loaded bone ... second stage of a two-stage revision ...
Occu-Flo Plugs Offer: , Easy Insertion , A polished, smooth, transparent finish which creates immediate patient comfort and adaptation , High tolerance by patients , No discomfort should removal be ...
Medicine Products: